Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- 3 Dividend Stocks at Reasonable Prices
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On January 10, we initiated our coverage on regional bank, Prosperity Bancshares Inc. ( PB - Analyst Report ) at Neutral based on its strong growth prospects and continuously falling expenses. However, significant exposure to real estate loan portfolio and stringent regulatory landscape remain the major causes of concern for this Zacks Rank #2 (Buy) stock.
Why the Neutral Stance?
Prosperity’s significant appetite for acquisitions, steady top-line growth and continuously improving credit quality prompted us to initiate with this stance. Further, the company continues to witness a decline in non-interest expenses without resorting to any cost-cutting initiative. Moreover, with a stable capital position and regular dividend payments, Prosperity remains an asset for yield-seeking investors.
However, as a result of the low interest rate environment Prosperity is expected to continue experiencing pressure on its net interest margin. Also, given its significant exposure to the real estate markets, we believe that the company’s financial performance will likely be adversely impacted. In addition, the company’s profitability remains vulnerable to the stringent regulatory landscape and absence of geographical diversification.
Further, in the third quarter of 2012, Prosperity marginally beat the Zacks Consensus Estimate aided by top-line growth, partially offset by higher operating expenses. The company is scheduled to announce its fourth-quarter results on January 25.
The Zacks Consensus Estimate for the fourth quarter is pegged at 84 cents per share. Earnings ESP (Expected Surprise Prediction), the percentage difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for Prosperity is nil. This implies that the company will report earnings in line with the Zacks Consensus Estimate in the fourth quarter.
Other Stocks to Consider
Besides Prosperity, other stocks in the financial industry that are currently performing well include Cardinal Financial Corp. ( CFNL - Snapshot Report ) and IberiaBank Corp. ( IBKC - Snapshot Report ) . These two companies carry a Zacks Rank #1 (Strong Buy).
Read the full Snapshot Report on IBKC
Read the full Snapshot Report on CFNL
Read the full Analyst Report on PB